GLAXO GROUP LIMITED
Patent Owner
Stats
- 536 US PATENTS IN FORCE
- 18 US APPLICATIONS PENDING
- Jan 09, 2018 most recent publication
Details
- 536 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 28,457 Total Citation Count
- Apr 24, 1978 Earliest Filing
- 1,492 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0317,398 DENTIFRICE COMPOSITION COMPRISING SPHERICAL FUSED ALUMINUM OXIDE PARTICLESDec 17, 14Nov 03, 16[A61K, A61Q]
2016/0228,341 Dentifrice Composition Comprising Sintered HydroxyapatiteSep 24, 14Aug 11, 16[A61K, A61Q]
2016/0151,588 Pharmaceutical Metered Dose Inhaler and Methods Relating TheretoFeb 05, 16Jun 02, 16[A61K, A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9850307 Nucleic acids encoding immunoglobulins that bind TGF-beta receptor IISep 02, 15Dec 26, 17[C12N, C07K]
9795561 Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseasesDec 17, 13Oct 24, 17[A61J, A61K]
9750726 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonistDec 16, 15Sep 05, 17[A61K, A01N, B65D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0069,826 Sample Plate for An X-Ray Powder Diffraction ApparatusAbandonedNov 05, 15Mar 10, 16[G01N]
2015/0342,897 POLYPEPTIDE LOADED POCA NANOPARTICLES FOR ORAL ADMINISTRATIONAbandonedMay 16, 13Dec 03, 15[A61K]
2015/0306,058 COMPOSITION COMPRISING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESYLATE (CM)AbandonedAug 21, 13Oct 29, 15[A61K]
2015/0251,148 Container System for Mixing and Dispensing a DrinkAbandonedNov 01, 13Sep 10, 15[A23L, A47J, B01F]
2015/0210,767 STABLE ANTI-TNFR1 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTSAbandonedApr 09, 15Jul 30, 15[C07K]
2015/0209,319 COMPOSITIONS COMPRISING AN ANTIBODY AND CAMOSTAT MESYLATE (CM)AbandonedAug 21, 13Jul 30, 15[A61K]
2015/0203,851 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCERAbandonedSep 04, 13Jul 23, 15[C12N, G01N]
2015/0093,440 AGGREGATE NANOPARTICULATE MEDICAMENT FORMULATIONS, MANUFACTURE AND USE THEREOFAbandonedOct 13, 11Apr 02, 15[A61K]
2015/0017,671 METHODS FOR DETECTING LP-PLA2 ACTIVITY AND INHIBITION OF LP-PLA2 ACTIVITYAbandonedSep 26, 14Jan 15, 15[C12Q]
2014/0335,083 METHODS OF TREATMENT AND PREVENTION OF EYE DISEASESAbandonedNov 30, 12Nov 13, 14[A61K, C07D]
2014/0311,977 USE OF ORGANIC SOLVENT NANOFILTRATION AND LIQUID-LIQUID CHROMATOGRAPHY FOR THE RECOVERY OF PHARMACEUTICAL PRODUCTSAbandonedNov 20, 12Oct 23, 14[B01D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.